who is a candidate for glp-1 Are you good medication? Here what most platforms are not telling you. 💊, GLP-1 drugs like semaglutide and tirzepatide are revolutionary. They are changing the landscape of Who is a good candidate

The most striking protective effects of SGLT2is were a marked reduction in hospitalization for heart failure and a remarkable reduced progression of chronic kidney disease

We will continue to monitor the phenomenal up-take of GLP-1 drugs (recognizing its growing pipeline shown in the chart above) and patients perspectives of the use of these medications both those people prescribed them to treat medical obesity and those consumers willing to pay for them out-of-pocket

Explore the dual nature of GLP-1 receptor agonists in colorectal cancer

They have a tremendous amount of disease burden, []

Understanding payer policies, genetic predispositions, and alternative access routes can improve approval odds and reduce out-of-pocket costs

Learn why the introduction of Orforglipron (Foundayo) marks a meaningful shift in GLP1 therapy.